Illumina stock skidded Tuesday after China signaled it would ban the company from importing its gene-mapping products.

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and ...

The stock dropped roughly 5.5% Tuesday morning. ↘️ Delta Air Lines (DAL): The carrier cut its outlook, as did American Airlines (AAL) and JetBlue (JBLU). Illumina is reducing its forecast for ...

That morning, Barclays changed its recommendation on Illumina stock to underweight (read: sell) from the previous equal weight (hold). It also pulled the lever on a significant price target ...

The stock's rise snapped a four-day losing streak.

In a report released today, Canaccord Genuity also maintained a Hold rating on the stock with a $115.00 price target. Based on Illumina’s latest earnings release for the quarter ending December ...

Illumina (ILMN) is reducing its forecast for ... actions to protect our earnings,” Dhingra said. Effectively assess a stock's risks and opportunities with a clear breakdown of its positive ...

Illumina Inc (NASDAQ:ILMN ... a shifting competitive landscape and global economic challenges. The company's stock has been the subject of intense scrutiny by analysts, with opinions varying ...